The use of a Dabigatran-Specific Reversal Agent- Budget Impact Analysis from the Hospital Perspective and the French Public Payer Perspective
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1493
https://www.valueinhealthjournal.com/article/S1098-3015(16)32859-5/fulltext
Title :
The use of a Dabigatran-Specific Reversal Agent- Budget Impact Analysis from the Hospital Perspective and the French Public Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32859-5&doi=10.1016/j.jval.2016.09.1493
First page :
A606
Section Title :
Health Care Treatment Studies
Open access? :
No
Section Order :
1407